Key Points
-
Crosstalk between pattern recognition receptors (PRRs) expressed by dendritic cells orchestrates T helper (TH) cell differentiation through the induction of specific cytokine expression profiles, tailored to invading pathogens. C-type lectin receptors (CLRs) have an important role in orchestrating the induction of signalling pathways that regulate adaptive immune responses.
-
CLRs can control adaptive immunity at various levels by inducing signalling on their own, through crosstalk with other PRRs or by inducing carbohydrate-specific signalling pathways.
-
DC-specific ICAM3-grabbing non-integrin (DC-SIGN) interacts with mannose-carrying pathogens including Mycobacterium tuberculosis, HIV-1, measles virus and Candida albicans to activate the serine/threonine protein kinase RAF1. RAF1 signalling leads to the acetylation of Toll-like receptor (TLR)-activated nuclear factor-κB (NF-κB) subunit p65 and affects cytokine expression, such as inducing the upregulation of interleukin-10 (IL-10).
-
DC-associated C-type lectin 1 (dectin 1) triggering by a broad range of fungal pathogens, such as C. albicans, Aspergillus fumigatus and Pneumocystis carinii, results in protective antifungal immunity through the crosstalk of two independent signalling pathways — one through spleen tyrosine kinase (SYK) and one through RAF1 — that are essential for the expression of TH1 and TH17 cell polarizing cytokines.
-
Crosstalk between the SYK and RAF1 pathways is both synergistic and antagonizing to fine-tune NF-κB activity: although Ser276 phosphorylation of p65 leads to enhanced transcriptional activity of p65 itself through acetylation, it also inhibits the transcriptional activity of the NF-κB subunit RELB by sequestering it in p65–RELB dimers, which are transcriptionally inactive.
-
The diversity in CLR-mediated signalling provides some major challenges for the researches to elucidate and manipulate the signalling properties of this exciting family of receptors. However, the recent advances strongly support the use of CLR targeting vaccination strategies using dendritic cells to induce or redirect adaptive immune responses as well as improve antigen delivery.
Abstract
C-type lectin receptors (CLRs) expressed by dendritic cells are crucial for tailoring immune responses to pathogens. Following pathogen binding, CLRs trigger distinct signalling pathways that induce the expression of specific cytokines which determine T cell polarization fates. Some CLRs can induce signalling pathways that directly activate nuclear factor-κB, whereas other CLRs affect signalling by Toll-like receptors. Dissecting these signalling pathways and their effects on host immune cells is essential to understand the molecular mechanisms involved in the induction of adaptive immune responses. In this Review we describe the role of CLR signalling in regulating adaptive immunity and immunopathogenesis and discuss how this knowledge can be harnessed for the development of innovative vaccination approaches.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
206,07 € per year
only 17,17 € per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout





Similar content being viewed by others
References
Steinman, R. M. & Banchereau, J. Taking dendritic cells into medicine. Nature 449, 419–426 (2007).
Akira, S., Uematsu, S. & Takeuchi, O. Pathogen recognition and innate immunity. Cell 124, 783–801 (2006).
Gringhuis, S. I. et al. C-type lectin DC-SIGN modulates Toll-like receptor signaling via Raf-1 kinase-dependent acetylation of transcription factor NF-κB. Immunity 26, 605–616 (2007). This study identifies the RAF1 signalling pathway as being involved in the modulation of immune responses by DC-SIGN.
Gringhuis, S. I. et al. Dectin-1 directs T helper cell differentiation by controlling noncanonical NF-κB activation through Raf-1 and SYK. Nature Immunol. 10, 203–213 (2009). This study shows that T H cell differentiation is tailored to the pathogen through the integration of two signalling pathways induced by dectin 1; one through RAF1 and one through SYK.
Rogers, N. C. et al. SYK-dependent cytokine induction by Dectin-1 reveals a novel pattern recognition pathway for C type lectins. Immunity 22, 507–517 (2005). This is the first study to show that SYK is essential for dectin 1-induced immunity.
Meyer-Wentrup, F. et al. DCIR is endocytosed into human dendritic cells and inhibits TLR8-mediated cytokine production. J. Leukoc. Biol. 85, 518–525 (2009).
Zelensky, A. N. & Gready, J. E. The C-type lectin-like domain superfamily. FEBS J. 272, 6179–6217 (2005).
Rothfuchs, A. G. et al. Dectin-1 interaction with Mycobacterium tuberculosis leads to enhanced IL-12p40 production by splenic dendritic cells. J. Immunol. 179, 3463–3471 (2007).
van Kooyk, Y. & Rabinovich, G. A. Protein-glycan interactions in the control of innate and adaptive immune responses. Nature Immunol. 9, 593–601 (2008).
Sato, K. et al. Dectin-2 is a pattern recognition receptor for fungi that couples with the Fc receptor γ chain to induce innate immune responses. J. Biol. Chem. 281, 38854–38866 (2006).
Cao, W. et al. BDCA2/Fc ɛRIγ complex signals through a novel BCR-like pathway in human plasmacytoid dendritic cells. PLoS Biol. 5, e248 (2007). This study demonstrates that C-type lectin BDCA2 pairs with a signalling adaptor molecule to induce B cell receptor-like signalling.
Yamasaki, S. et al. Mincle is an ITAM-coupled activating receptor that senses damaged cells. Nature Immunol. 9, 1179–1188 (2008).
Bakker, A. B. H., Baker, E., Sutherland, G. R., Phillips, J. H. & Lanier, L. L. Myeloid DAP12-associating lectin (MDL)-1 is a cell surface receptor involved in the activation of myeloid cells. Proc. Natl Acad. Sci. USA 96, 9792–9796 (1999).
Marshall, A. S. et al. Identification and characterization of a novel human myeloid inhibitory C-type lectin-like receptor (MICL) that is predominantly expressed on granulocytes and monocytes. J. Biol. Chem. 279, 14792–14802 (2004).
Richard, M., Thibault, N., Veilleux, P., Gareau-Pagé, G. & Beaulieu, A. D. Granulocyte macrophage-colony stimulating factor reduces the affinity of SHP-2 for the ITIM of CLECSF6 in neutrophils: a new mechanism of action for SHP-2. Mol. Immunol. 43, 1716–1721 (2006).
Chen, C. H. et al. Dendritic-cell-associated C-type lectin 2 (DCAL-2) alters dendritic-cell maturation and cytokine production. Blood 107, 1459–1467 (2006).
Gross, O. et al. Card9 controls a non-TLR signalling pathway for innate anti-fungal immunity. Nature 442, 651–656 (2006). This is a key study showing that non-TLRs such as CLRs require CARD9–BCL-10–MALT1 signalling to induce immunity.
Yamasaki, S. et al. C-type lectin Mincle is an activating receptor for pathogenic fungus, Malassezia. Proc. Natl Acad. Sci. USA 106, 1897–1902 (2009).
Goriely, S., Neurath, M. F. & Goldman, M. How microorganisms tip the balance between interleukin-12 family members. Nature Rev. Immunol. 8, 81–86 (2008).
Geijtenbeek, T. B. H. et al. Mycobacteria target DC-SIGN to suppress dendritic cell function. J. Exp. Med. 197, 7–17 (2003).
Wellbrock, C., Karasarides, M. & Marais, R. The Raf proteins take centre stage. Nature Rev. Mol. Cell Biol. 5, 875–885 (2004).
Hodges, A. et al. Activation of the lectin DC-SIGN induces an immature dendritic cell phenotype triggering Rho-GTPase activity required for HIV-1 replication. Nature Immunol. 8, 569–577 (2007).
Chen, L.-F. et al. NF-κB RelA phosphorylation regulates RelA acetylation. Mol. Cell. Biol. 25, 7966–7975 (2005).
Chen, L. F., Mu, Y. & Greene, W. C. Acetylation of RelA at discrete sites regulates distinct nuclear functions of NF-κB. EMBO J. 21, 6539–6548 (2002). This report describes the importance of p65–RELA acetylation in controlling gene transcription.
Caparros, E. et al. DC-SIGN ligation on dendritic cells results in ERK and PI3K activation and modulates cytokine production. Blood 107, 3950–3958 (2006).
Shreffler, W. G. et al. The major glycoprotein allergen from Arachis hypogaea, Ara h 1, is a ligand of dendritic cell-specific ICAM-grabbing nonintegrin and acts as a Th2 adjuvant in vitro. J. Immunol. 177, 3677–3685 (2006).
Agrawal, S. et al. Different Toll-like receptor agonists instruct dendritic cells to induce distinct Th responses via differential modulation of extracellular signal-regulated kinase–mitogen-activated protein kinase and c-fos. J. Immunol. 171, 4984–4989 (2003).
Shan, M. et al. HIV-1 gp120 mannoses induce immunosuppressive responses from dendritic cells. PLoS Pathog. 3, e169 (2007).
Hovius, J. W. et al. Salp15 binding to DC-SIGN inhibits cytokine expression by impairing both nucleosome remodeling and mRNA stabilization. PLoS Pathog. 4, e31 (2008).
Garg, R. et al. CD4 is the receptor for the tick saliva immunosuppressor, Salp15. J. Immunol. 177, 6579–6583 (2006).
Rock, J. et al. CD303 (BDCA-2) signals in plasmacytoid dendritic cells via a BCR-like signalosome involving Syk, Slp65 and PLCγ2. Eur. J. Immunol. 37, 3564–3575 (2007).
Hara, H. et al. The adaptor protein CARD9 is essential for the activation of myeloid cells through ITAM-associated and Toll-like receptors. Nature Immunol. 8, 619–629 (2007). This study shows that the activation of lymphoid and myeloid cells through ITAM-associated receptors or TLRs is regulated by CARMA1–BCL-10 and CARD9–BCL-10, respectively.
Dzionek, A. et al. BDCA-2, a novel plasmacytoid dendritic cell-specific type II C-type lectin, mediates antigen capture and is a potent inhibitor of interferon α/β induction. J. Exp. Med. 194, 1823–1834 (2001).
Kang, Y. J. et al. Calcineurin negatively regulates TLR-mediated activation pathways. J. Immunol. 179, 4598–4607 (2007).
Hamerman, J. A. et al. Inhibition of TLR and FcR responses in macrophages by triggering receptor expressed on myeloid cells (TREM)-2 and DAP12. J. Immunol. 177, 2051–2055 (2006).
Turnbull, I. R. et al. TREM-2 attenuates macrophage activation. J. Immunol. 177, 3520–3524 (2006).
Ivashkiv, L. B. A signal-switch hypothesis for cross-regulation of cytokine and TLR signalling pathways. Nature Rev. Immunol. 8, 816–822 (2008).
Meyer-Wentrup, F. et al. Targeting DCIR on human plasmacytoid dendritic cells results in antigen presentation and inhibits IFN-α production. Blood 111, 4245–4253 (2008).
Chong, Z. Z. & Maiese, K. The Src homology 2 domain tyrosine phosphatases SHP-1 and SHP-2: diversified control of cell growth, inflammation, and injury. Histol. Histopathol. 22, 1251–1267 (2007).
An, H. et al. Phosphatase SHP-1 promotes TLR- and RIG-I-activated production of type I interferon by inhibiting the kinase IRAK1. Nature Immunol. 9, 542–550 (2008).
An, H. et al. SHP-2 phosphatase negatively regulates the TRIF adaptor protein-dependent type I interferon and proinflammatory cytokine production. Immunity 25, 919–928 (2006).
Saijo, S. et al. Dectin-1 is required for host defense against Pneumocystis carinii but not against Candida albicans. Nature Immunol. 8, 39–46 (2007).
Taylor, P. R. et al. Dectin-1 is required for β-glucan recognition and control of fungal infection. Nature Immunol. 8, 31–38 (2007).
Underhill, D. M., Rossnagle, E., Lowell, C. A. & Simmons, R. M. Dectin-1 activates SYK tyrosine kinase in a dynamic subset of macrophages for reactive oxygen production. Blood 106, 2543–2550 (2005).
Rawlings, D. J., Sommer, K. & Moreno-Garcia, M. E. The CARMA1 signalosome links the signalling machinery of adaptive and innate immunity in lymphocytes. Nature Rev. Immunol. 6, 799–812 (2006).
Ferch, U. et al. MALT1 directs B cell receptor-induced canonical nuclear factor-κ B signaling selectively to the c-Rel subunit. Nature Immunol. 8, 984–991 (2007).
Claudio, E., Brown, K., Park, S., Wang, H. & Siebenlist, U. BAFF-induced NEMO-independent processing of NF-κB2 in maturing B cells. Nature Immunol. 3, 958–965 (2002).
Dejardin, E. et al. The lymphotoxin-β receptor induces different patterns of gene expression via two NF-κB pathways. Immunity 17, 525–535 (2002).
Gross, O. et al. Syk kinase signalling couples to the Nlrp3 inflammasome for anti-fungal host defence. Nature 1 Apr 2009 (doi: 10.1038/nature07965).
Mencacci, A. et al. Interleukin 18 restores defective Th1 immunity to Candida albicans in caspase 1-deficient mice. Infect. Immun. 68, 5126–5131 (2000).
Carmody, R. J., Ruan, Q. G., Liou, H. C. & Chen, Y. H. H. Essential roles of c-Rel in TLR-induced IL-23 p19 gene expression in dendritic cells. J. Immunol. 178, 186–191 (2007).
Jacque, E., Tchenio, T., Piton, G., Romeo, P.-H. & Baud, V. RelA repression of RelB activity induces selective gene activation downstream of TNF receptors. Proc. Natl Acad. Sci. USA 102, 14635–14640 (2005). This report identifies a new mechanism that regulates RELB activity by inducing inactive RELB–p65 dimers.
Marienfeld, R. et al. RelB forms transcriptionally inactive complexes with RelA/p65. J. Biol. Chem. 278, 19852–19860 (2003).
Manel, N., Unutmaz, D. & Littman, D. R. The differentiation of human TH-17 cells requires transforming growth factor-β and induction of the nuclear receptor RORγt. Nature Immunol. 9, 641–649 (2008).
Volpe, E. et al. A critical function for transforming growth factor-β, interleukin 23 and proinflammatory cytokines in driving and modulating human TH-17 responses. Nature Immunol. 9, 650–657 (2008).
Yang, L. et al. IL-21 and TGF-β are required for differentiation of human TH17 cells. Nature 454, 350–352 (2008).
Murphy, K. M. & Reiner, S. L. The lineage decisions of helper T cells. Nature Rev. Immunol. 2, 933–944 (2002).
Barrett, N. A., Maekawa, A., Rahman, O. M., Austen, K. F. & Kanaoka, Y. Dectin-2 recognition of house dust mite triggers cysteinyl leukotriene generation by dendritic cells. J. Immunol. 182, 1119–1128 (2009).
Sorgi, C. A. et al. Histoplasma capsulatum cell wall β-glucan induces lipid body formation through CD18, TLR2, and dectin-1 receptors: correlation with leukotriene B4 generation androle in HIV-1 infection. J. Immunol. 182, 4025–4035 (2009).
Khader, S. A. et al. IL-23 and IL-17 in the establishment of protective pulmonary CD4+ T cell responses after vaccination and during Mycobacterium tuberculosis challenge. Nature Immunol. 8, 369–377 (2007).
Madura Larsen, J. et al. BCG stimulated dendritic cells induce an interleukin-10 producing T-cell population with no T helper 1 or T helper 2 bias in vitro. Immunology 121, 276–282 (2007).
Gerosa, F. et al. Differential regulation of interleukin 12 and interleukin 23 production in human dendritic cells. J. Exp. Med. 205, 1447–1461 (2008).
Yadav, M. & Schorey, J. S. The β-glucan receptor dectin-1 functions together with TLR2 to mediate macrophage activation by mycobacteria. Blood 108, 3168–3175 (2006).
Werninghaus, K. et al. Adjuvanticity of a synthetic cord factor analogue for subunit Mycobacterium tuberculosis vaccination requires FcRγ–Syk–Card9-dependent innate immune activation. J. Exp. Med. 206, 89–97 (2009).
LeibundGut-Landmann, S. et al. Syk- and CARD9-dependent coupling of innate immunity to the induction of T helper cells that produce interleukin 17. Nature Immunol. 8, 630–638 (2007). This report describes the importance of the SYK-dependent CARD9–BCL-10–MALT1 complex in inducing T H 17 cell responses to fungi.
Netea, M. G., Brown, G. D., Kullberg, B. J. & Gow, N. A. R. An integrated model of the recognition of Candida albicans by the innate immune system. Nature Rev. Microbiol. 6, 67–78 (2008).
Dillon, S. et al. Yeast zymosan, a stimulus for TLR2 and dectin-1, induces regulatory antigen-presenting cells and immunological tolerance. J. Clin. Invest. 116, 916–928 (2006).
Geijtenbeek, T. B. H. et al. DC-SIGN, a dendritic cell-specific HIV-1-binding protein that enhances trans-infection of T cells. Cell 100, 587–597 (2000).
Chen, S. T. et al. CLEC5A is critical for dengue-virus-induced lethal disease. Nature 453, 672–676 (2008). This study shows that CLEC5A-induced immune responses are causing virus pathogenesis.
Wu, P. et al. TLR9/TLR7-triggered downregulation of BDCA2 expression on human plasmacytoid dendritic cells from healthy individuals and lupus patients. Clin. Immunol. 129, 40–48 (2008).
Ronninger, M., Eklow, C., Lorentzen, J. C., Klareskog, L. & Padyukov, L. Differential expression of transcripts for the autoimmunity-related human dendritic cell immunoreceptor. Genes Immun. 9, 412–418 (2008).
Fujikado, N. et al. Dcir deficiency causes development of autoimmune diseases in mice due to excess expansion of dendritic cells. Nature Med. 14, 176–180 (2008).
Palucka, A. K., Ueno, H., Fay, J. W. & Banchereau, J. Taming cancer by inducing immunity via dendritic cells. Immunol. Rev. 220, 129–150 (2007).
Tacken, P. J., de Vries, I. J., Torensma, R. & Figdor, C. G. Dendritic-cell immunotherapy: from ex vivo loading to in vivo targeting. Nature Rev. Immunol. 7, 790–802 (2007).
Bozzacco, L. et al. DEC-205 receptor on dendritic cells mediates presentation of HIV gag protein to CD8+ T cells in a spectrum of human MHC I haplotypes. Proc. Natl Acad. Sci. USA 104, 1289–1294 (2007).
Bonifaz, L. C. et al. In vivo targeting of antigens to maturing dendritic cells via the DEC-205 receptor improves T cell vaccination. J. Exp. Med. 199, 815–824 (2004).
Mukhopadhaya, A. et al. Selective delivery of β cell antigen to dendritic cells in vivo leads to deletion and tolerance of autoreactive CD8+ T cells in NOD mice. Proc. Natl Acad. Sci. USA 105, 6374–6379 (2008). This study shows that CLR targeting as a vaccination approach prevents autoimmunity by inducing antigen-specific tolerance.
Sancho, D. et al. Identification of a dendritic cell receptor that couples sensing of necrosis to immunity. Nature 458, 899–903 (2009).
Yoshitomi, H. et al. A role for fungal β-glucans and their receptor dectin-1 in the induction of autoimmune arthritis in genetically susceptible mice. J. Exp. Med. 201, 949–960 (2005).
Karumuthil-Melethil, S., Perez, N., Li, R. & Vasu, C. Induction of innate immune response through TLR2 and dectin 1 prevents type 1 diabetes. J. Immunol. 181, 8323–8334 (2008). This report describes the use of CLR ligands as a vaccination approach to prevent autoimmunity.
Goodridge, H. S. et al. Differential use of CARD9 by dectin-1 in macrophages and dendritic cells. J. Immunol. 182, 1146–1154 (2009).
Sancho, D. et al. Tumor therapy in mice via antigen targeting to a novel, DC-restricted C-type lectin. J. Clin. Invest 118, 2098–2110 (2008).
Hawiger, D. et al. Dendritic cells induce peripheral T cell unresponsiveness under steady state conditions in vivo. J. Exp. Med. 194, 769–780 (2001). This is the first study to show that targeting of CLRs in vivo induces antigen-specific tolerance.
Merad, M., Ginhoux, F. & Collin, M. Origin, homeostasis and function of Langerhans cells and other langerin-expressing dendritic cells. Nature Rev. Immunol. 8, 935–947 (2008).
Appelmelk, B. J. et al. Carbohydrate profiling identifies new pathogens that interact with dendritic cell-specific ICAM-3-grabbing nonintegrin on dendritic cells. J. Immunol. 170, 1635–1639 (2003).
Bergman, M. P. et al. Helicobacter pylori modulates the T helper cell 1/T helper cell 2 balance through phase-variable interaction between lipopolysaccharide and DC-SIGN. J. Exp. Med. 200, 979–990 (2004).
Smits, H. H. et al. Selective probiotic bacteria induce IL-10-producing regulatory T cells in vitro by modulating dendritic cell function through dendritic cell-specific intercellular adhesion molecule 3-grabbing nonintegrin. J. Allergy Clin. Immunol. 115, 1260–1267 (2005).
León, B., López-Bravo, M. & Ardavín, C. Monocyte-derived dendritic cells formed at the infection site control the induction of protective T helper 1 responses against Leishmania. Immunity 26, 519–531 (2007).
van Liempt, E. et al. Schistosoma mansoni soluble egg antigens are internalized by human dendritic cells through multiple C-type lectins and suppress TLR-induced dendritic cell activation. Mol. Immunol. 44, 2605–2615 (2007).
Smith, A. L. et al. Leukocyte-specific protein 1 interacts with DC-SIGN and mediates transport of HIV to the proteasome in dendritic cells. J. Exp. Med. 204, 421–430 (2007).
Tassaneetrithep, B. et al. DC-SIGN (CD209) mediates dengue virus infection of human dendritic cells. J. Exp. Med. 197, 823–829 (2003).
de Witte, L. et al. DC-SIGN and CD150 have distinct roles in transmission of measles virus from dendritic cells to T-lymphocytes. PLoS Pathog. 4, e1000049 (2008).
Marzi, A. et al. DC-SIGN and DC-SIGNR interact with the glycoprotein of Marburg virus and the S protein of severe acute respiratory syndrome coronavirus. J. Virol. 78, 12090–12095 (2004).
de Witte, L. et al. Langerin is a natural barrier to HIV-1 transmission by Langerhans cells. Nature Med. 13, 367–371 (2007).
Hunger, R. E. et al. Langerhans cells utilize CD1a and langerin to efficiently present nonpeptide antigens to T cells. J. Clin. Invest. 113, 701–708 (2004).
van Vliet, S. J., Saeland, E. & van Kooyk, Y. Sweet preferences of MGL: carbohydrate specificity and function. Trends Immunol. 29, 83–90 (2008).
Inui, M. et al. Signal adaptor DAP10 associates with MDL-1 and triggers osteoclastogenesis in cooperation with DAP12. Proc. Natl Acad. Sci. USA 106, 4816–4821 (2009).
Xu, S., Huo, J., Lee, K. G., Kurosaki, T. & Lam, K. P. Phospholipase Cγ2 is critical for dectin-1-mediated Ca2+ flux and cytokine production in dendritic cells. J. Biol. Chem. 284, 7038–7046 (2009).
Chaipan, C. et al. DC-SIGN and CLEC-2 mediate human immunodeficiency virus type 1 capture by platelets. J. Virol. 80, 8951–8960 (2006).
Fuller, G. L. J. et al. The C-type lectin receptors CLEC-2 and dectin-1, but not DC-SIGN, signal via a novel YXXL-dependent signalling cascade. J. Biol. Chem. 282, 12397–12409 (2007).
Pleines, I. et al. Rac1 is essential for phospholipase C-γ2 activation in platelets. Eur. J. Physiol. 457, 1173–1185 (2008).
Caminschi, I. et al. The dendritic cell subtype-restricted C-type lectin Clec9A is a target for vaccine enhancement. Blood 112, 3264–3273 (2008).
Hoffmann, S. C. et al. Identification of CLEC12B, an inhibitory receptor on myeloid cells. J. Biol. Chem. 282, 22370–22375 (2007).
Gazi, U. & Martinez-Pomares, L. Influence of the mannose receptor in host immune responses. Immunobiol. 21 Jan 2009 (doi: 10.1016/j.imbio.2008.11.004).
Miller, J. L. et al. The mannose receptor mediates dengue virus infection of macrophages. PLoS Pathog. 4, e17 (2008).
Zhang, J. et al. Cdc42 and RhoB activation are required for mannose receptor-mediated phagocytosis by human alveolar macrophages. Mol. Biol. Cell 16, 824–834 (2005).
Acknowledgements
We thank the members of the Host–Pathogen Interactions group for their valuable input. S.I.G. and T.B.H.G. are supported by the Dutch Asthma Foundation (grant number 3.2.03.39) and the Dutch Scientific Research program (grant number NWO VIDI 917-46-367), respectively.
Author information
Authors and Affiliations
Corresponding author
Related links
Glossary
- T helper (TH) cell
-
A T cell subset that secretes a distinct set of cytokines after activation, which occurs through the ligation of the T cell receptor with its cognate ligand (peptide–MHC complex), together with the recognition of the appropriate co-stimulatory molecules. Naive TH cells differentiate into TH1, TH2 or TH17 cells, depending on the cytokines and co-stimulatory molecules presented to them by antigen-presenting cells.
- Regulatory T cell
-
A T cell belonging to a specialized subset of CD4+ T cells that suppresses immune responses to maintain tolerance to antigens, including self antigens.
- Pathogen-associated molecular pattern
-
A small conserved molecular motif that is consistently found on pathogens; for example, lipopolysaccharides, carbohydrate moieties, double-stranded RNA and unmethylated DNA motifs.
- Tonic calcium signalling
-
Signalling that is characterized by sustained increased basal intracellular calcium levels, which induces constitutive calcineurin activity. Tonic calcium signalling occurs as a result of exposure of ITAM-coupled receptors to low-avidity ligands.
- Canonical NF-κB pathway
-
A pathway that involves the activation of IκB kinase-β (IKKβ), which leads to phosphorylation-induced proteolysis of inhibitor of NF-κB (IκB) and consequent nuclear translocation of the nuclear factor-κB (NF-κB) subunits p65, REL and p50.
- Non-canonical NF-κB pathway
-
A pathway that involves the activation of IκB kinase-α (IKKα) by NF-κB-inducing kinase (NIK), which results in the processing of the nuclear factor-κB (NF-κB) subunits p100 to p52 and consequent formation of RelB–p52 dimers, which translocate into the nucleus and activate gene transcription.
- Tolerance
-
A state of lymphocyte non-responsiveness to antigen. The term implies an active process, not simply a passive lack of response.
- Systemic lupus erythematosus
-
(SLE). An autoimmune disease in which autoantibodies that are specific for DNA, RNA or proteins associated with nucleic acids form immune complexes that damage small blood vessels, especially in the kidney. Patients with SLE generally have abnormal B and T cell function.
- Rheumatoid arthritis
-
An autoimmune disease that leads to chronic inflammation in the joints and subsequent destruction of the cartilage and erosion of the bone. It is divided into two main phases: initiation and establishment of autoimmunity to collagen-rich joint components, and later events associated with the evolving destructive inflammatory processes.
Rights and permissions
About this article
Cite this article
Geijtenbeek, T., Gringhuis, S. Signalling through C-type lectin receptors: shaping immune responses. Nat Rev Immunol 9, 465–479 (2009). https://doi.org/10.1038/nri2569
Issue Date:
DOI: https://doi.org/10.1038/nri2569